Medexus Pharmaceuticals Inc. ( MEDXF) - Key Metrics
MEDXF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | ? | ? | ? | ? |
| 2026Q3 | $1.09 | $0 | $0.24 | $0.24 |
| 2026Q2 | $0.77 | -$0.01 | $0.10 | $0.10 |
| 2026Q1 | $0.76 | $0.02 | $0.12 | $0.12 |
| 2025Q4 | $0.96 | -$0.02 | $0.09 | $0.09 |
MEDXF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | ? | ? |
| 2026Q3 | ? | 211.50 |
| 2026Q2 | ? | -66.63 |
| 2026Q1 | ? | 49.54 |
| 2025Q4 | ? | -28.25 |
MEDXF
Price: $3.65
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -114.50
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 114.3 million